Epidemiological study using molecular biologic markers
Tsugane, S.
Gan no Rinsho. Japan Journal of Cancer Clinics 35(2): 229-233
1989
ISSN/ISBN: 0021-4949 PMID: 2649706 Document Number: 341835
It seems to be important for the epidemiological study on cancer etiology to conduct molecular biological approach. IARC/WHO held "International Course on Molecular Biology for Epidemiologist" in order to promote the molecular epidemiology. I described here the content of the course and our study on lung cancer etiology using c-Ha-ras VTR marker of leukocyte DNA in peripheral blood, and discussed the possibility of molecular epidemiology.
Document emailed within 1 workday
Related Documents
Aparicio, P.; Román, F.; Campos, J. 1996: Epidemiological characterization of Haemophilus influenzae using molecular markers Enfermedades Infecciosas y Microbiologia Clinica 14(4): 227-232Nagai, N. 1990: Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA Nihon Sanka Fujinka Gakkai Zasshi 42(8): 823-833
Meitert, T.; Meitert, E. 1981: Epidemiological and immunobiological implications of Pseudomonas aeruginosa epidemiological markers Archives Roumaines de Pathologie Experimentales et de Microbiologie 40(1): 5-23
Cogliati, M.; Tortorano, A.M.; Viviani, M.A. 1999: Molecular typing technics in the epidemiological study of cryptococcosis Annali di Igiene: Medicina Preventiva e di Comunita 11(6): 497-500
Han, Z.; Leung, T.W.C.; Zhao, J.; Wang, M.; Fan, L.; Li, K.; Pang, X.; Liang, Z.; Lim, W.W.L.; Xu, H. 2009: A HIV-1 heterosexual transmission chain in Guangzhou, China: a molecular epidemiological study Virology Journal 6: 148
Yang, H.-t.; Xing, H.; Jia, C.-m.; Liang, H.; Xu, X.-q.; Wei, M.; Li, L.; Chen, Z.; Shao, Y.-m. 2003: A molecular epidemiological study on the human immunodeficiency virus infection in Jiangsu province Zhonghua Liu Xing Bing Xue Za Zhi 24(11): 976-979
Mufti, S.I.; Zirvi, K.A.; Garewal, H.S. 1991: Precancerous lesions and biologic markers in esophageal cancer Cancer Detection and Prevention 15(4): 291-301
Barzell, W.E.; Whitmore, W.F. 1979: Clinical significance of biologic markers: Memorial Hospital experience Seminars in Oncology 6(1): 48-52
Grechko, V.V.; Fedorova, L.V.; Riabinin, D.M.; Riabinina, N.L.; Chobanu, D.G.; Kosushkin, S.A.; Darevskiĭ, I.S. 2006: Molecular markers of nuclear DNA in the study of evolution and speciation process in an example of "Lacerta agilis complex" (Sauria: Lacertidae) Molekuliarnaia Biologiia 40(1): 61-73
Ben Salem, M.; Ghanem, N.; Kneissi, T.; Abbal, M.; Dugoujon, J.M.; Ben Chibani, J.; Ellouze, F.; Lefranc, G. 1991: Immunogenetic markers (BF, C2, C4, 21-OH, TNF alpha, TCR beta, Ig) and insulin-dependent diabetes in the Tunisian population: serological and molecular study Annales de Biologie Clinique 49(7): 389-396
Enta, K.; Iwade, K.; Aosaki, M.; Uchida, T.; Kasanuki, H. 2004: Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study Journal of Cardiology 44(6): 223-232
Bogovskiĭ, S.; Muzyka, V.; Riazanov, V.; Lang, I.; Shmidt, N.; Karlova, S.; Veĭmer, S.; Skepers, P.; Likhtenshteĭn, I.; Hartfill, G.D.; Kusova, I.; Michka, V. 2004: Biologic markers and occupational monitoring of human exposure to exhaust gases of diesel engines Meditsina Truda i Promyshlennaia Ekologiia 2004(8): 19-23
Lavrent'eva, I.N. 2008: Molecular and biologic characteristics of attenuated rubella viruses Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 55-59
Korneva, E.A.; Golovko, O.I.; Kazakova, T.V. 1997: Molecular-biologic aspects of interaction between nervous and immune systems Voprosy Meditsinskoi Khimii 43(5): 321-329
Lindner, J. 1982: Bones and skin: molecular biologic and pathologic similarities and differences Der Radiologe 22(12): 530-544
Heimann, A.; Scanlon, R.; Gentile, J.; MacConnell, P.; Nuovo, G.J. 1992: Measles cervicitis. Report of a case with cytologic and molecular biologic analysis Acta Cytologica 36(5): 727-730
Delattre, O. 1998: Contribution of cytogenetic and molecular biologic techniques to the diagnosis of round cell tumors in children Annales de Pathologie 18(5 Suppl): 91-92
Hladik, F.; Tratkiewicz, J.A.; Tilg, H.; Vogel, W.; Schwulera, U.; Krönke, M.; Aulitzky, W.E.; Huber, C. 1994: Biologic activity of low dosage IL-2 treatment in vivo. Molecular assessment of cytokine network interaction Journal of Immunology 153(4): 1449-1454
Watanabe, R.; Murata, M.; Takayama, N.; Tokuhira, M.; Kizaki, M.; Okamoto, S.; Kawai, Y.; Watanabe, K.; Murakami, H.; Kikuchi, M.; Nakamura, S.; Ikeda, Y. 1997: Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS) Thrombosis and Haemostasis 77(4): 641-645
Loubinoux, J.; Florent, M.; Merad, B.; Collobert, G.; Bouvet, A. 2004: Epidemiological markers of group A streptococcal infections in France Indian Journal of Medical Research 119(Suppl): 152-154